In this study, 4 NAFLD-related genes (DUSP1, NR4A1, FOSB, ZFP36) were identified as diagnostic markers in CKD patients, and NAFLD may accelerate the development of CKD through immune and inflammatory pathways. This evidence concerns the gene NR4A1 and metabolic dysfunction-associated steatotic liver disease.